Pharmaceutical giant Johnson & Johnson announced Thursday that it would not enforce its patents on its AIDS drug Prezista in the world’s poorest countries and throughout sub-Saharan Africa. Offering cost relief to people infected with the HIV virus, J&J said it wanted to assure manufacturers that they can freely produce…
NEW YORK — Pfizer and Johnson & Johnson said Monday they had given up tests of a new therapy to treat Alzheimer’s disease, saying the treatment did not measure up to expectations. The final, phase 3 trial of the intravenous bapineuzumab therapy did not meet targets for effectiveness in aiding…
Pharmaceutical giant Johnson & Johnson on Tuesday became the 19th company to cut ties with the American Legislative Exchange Council following a campaign launched by liberal and progressive groups. “We have been in dialogue with ALEC for some time, and while we acknowledge ALEC’s recent decision to focus only on…